Literature DB >> 23721944

Posterior iris-claw aphakic intraocular lens implantation in children.

Johannes Gonnermann1, Necip Torun, Matthias K J Klamann, Anna-Karina Maier, Christoph von Sonnleithner, Peter W Rieck, Eckart Bertelmann.   

Abstract

PURPOSE: To evaluate the indications, visual outcomes, and complication rate after posterior implantation of an iris-claw aphakic intraocular lens (IOL) in children.
DESIGN: Noncomparative retrospective cohort study.
METHODS: setting: Institutional practice. patients/intervention procedures: Seven eyes of 4 children without adequate capsular support had posterior chamber iris-claw aphakic IOL implantation between 2007 and 2012. main outcome measures: Visual acuity, endothelial cell changes, intraoperative and postoperative complications.
RESULTS: The mean age of the 3 boys and 1 girl was 12.0 ± 3.4 (SD) years (range 8-16 years). In all eyes, the mean postoperative best spectacle-corrected visual acuity (0.13 ± 0.17 logMAR) was statistically significantly better at the last follow-up than at 1 day preoperatively (0.60 ± 0.39 logMAR) (P < .05). The mean follow-up was 31 months (range 10-64 months). The mean endothelial cell density decreased from 3013 ± 155 cells/mm(2) preoperatively to 2831 ± 236 cells/mm(2) at last follow-up, representing a mean endothelial cell loss of 6.4%. No corneal decompensation, iritis, secondary glaucoma, or pupillary block occurred after surgery in any eye. Postoperative complications included transient postoperative hypotony in 1 eye and a traumatic dislocation of a posterior aphakic iris-claw IOL in 1 eye.
CONCLUSION: The posterior implantation technique of aphakic iris-claw IOL provided good visual outcomes with a favorable complication rate and can be used as a reasonable alternative for a wide range of indications in pediatric eyes without adequate capsular support.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23721944     DOI: 10.1016/j.ajo.2013.03.002

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  8 in total

1.  Experience of early implantation of retropupillary iris-claw intraocular lens in childhood.

Authors:  Göran Darius Hildebrand; Kanmin Xue
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-04-28       Impact factor: 3.117

2.  Complications and outcomes of descemet stripping automated endothelial keratoplasty with artisan aphakia intraocular lens implantation.

Authors:  Rong-Mei Peng; Yu-Xin Guo; Yuan Qiu; Yan-Sheng Hao; Jing Hong
Journal:  Int J Ophthalmol       Date:  2018-04-18       Impact factor: 1.779

3.  Retropupillary Fixation of Iris-Claw Intraocular Lens for Aphakic Eyes in Children.

Authors:  Martina Brandner; Sarah Thaler-Saliba; Sophie Plainer; Bertram Vidic; Yosuf El-Shabrawi; Navid Ardjomand
Journal:  PLoS One       Date:  2015-06-25       Impact factor: 3.240

4.  Peripheral iridectomy for preventing iris-related complications in glued intraocular lens surgery in children.

Authors:  Divya Balakrishnan; Avadhesh Oli; Remya M Paulose; Hasnat Ali
Journal:  Indian J Ophthalmol       Date:  2020-03       Impact factor: 1.848

Review 5.  Surgical Management of Paediatric Aphakia in the Absence of Sufficient Capsular Support.

Authors:  Evdoxia-Maria Karasavvidou; Craig Wilde; Anwar Zaman; Gavin Orr; Dharmalingam Kumudhan; Georgios D Panos
Journal:  J Ophthalmol       Date:  2021-12-04       Impact factor: 1.909

6.  Long Term Clinical and Visual Outcomes of Retrofixated Iris Claw Lenses Implantation in Complicated Cases.

Authors:  Sri Ganesh; Sheetal Brar; Kirti Relekar
Journal:  Open Ophthalmol J       Date:  2016-04-29

7.  Retropupillary iris-claw intraocular lens in ectopia lentis in Marfan syndrome.

Authors:  Mun Yueh Faria; Nuno Ferreira; Eliana Neto
Journal:  Int Med Case Rep J       Date:  2016-06-17

Review 8.  Cataract management in children: a review of the literature and current practice across five large UK centres.

Authors:  J E Self; R Taylor; A L Solebo; S Biswas; M Parulekar; A Dev Borman; J Ashworth; R McClenaghan; J Abbott; E O'Flynn; D Hildebrand; I C Lloyd
Journal:  Eye (Lond)       Date:  2020-08-10       Impact factor: 3.775

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.